|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0018284,
umls-concept:C0024264,
umls-concept:C0183683,
umls-concept:C0205179,
umls-concept:C0205210,
umls-concept:C0344211,
umls-concept:C1140680,
umls-concept:C1171411,
umls-concept:C1317973,
umls-concept:C1328050,
umls-concept:C1516213,
umls-concept:C1518999,
umls-concept:C1521721,
umls-concept:C2004454
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-1-22
|
|
pubmed:abstractText |
The purpose of this study was to investigate the clinical role of immunological recovery together with selected biological parameters on long-term survival in a series of ovarian cancer administered high-dose chemotherapy with peripheral blood stem cell and growth factor support.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
195-200
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12538469-Antigens, CD3,
pubmed-meshheading:12538469-Antigens, CD4,
pubmed-meshheading:12538469-Antigens, CD56,
pubmed-meshheading:12538469-Female,
pubmed-meshheading:12538469-Growth Substances,
pubmed-meshheading:12538469-Humans,
pubmed-meshheading:12538469-Immunohistochemistry,
pubmed-meshheading:12538469-Logistic Models,
pubmed-meshheading:12538469-Lymphocytes,
pubmed-meshheading:12538469-Ovarian Neoplasms,
pubmed-meshheading:12538469-Prognosis,
pubmed-meshheading:12538469-Receptors, IgG,
pubmed-meshheading:12538469-Risk
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications.
|
|
pubmed:affiliation |
Department of Gynecology, Catholic University of Rome, 00168 Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
